America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
College can be expensive, but saving money is possible. Learn practical ways to cut costs and keep your finances in check while studying.
27,554 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
NVIDIA's market value has surged as AI infrastructure demand powers a relentless rally. A single metric—this insane n...
IonQ stands at the crossroads of hype and real-world adoption in quantum computing. This ionq stock analysis: sell pi...
A new AI-driven forecast links regulatory resolution, ETF uptake, and RippleNet expansion to a potential XRP surge to...
A market wobble in 2026 didn’t push Berkshire into a rush of deals. Learn what Warren Buffett's stance on cash, risk,...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
The couple bought cheapest part of Medicare drug coverage, yet a separate IRMAA surcharge trimmed their Social Securi...
SpaceX is eyed for Nasdaq-100 inclusion via a Fast Entry rule. Learn what it means for investors, how to evaluate the...
A renowned marine biologist was shot dead in the Philippines after warning that coral loss could destabilize oceans. ...
A loose, little-regulated lending network is stepping in to help small businesses cover tariffs quickly, but with ste...
Institutional demand for Solana ETFs has reached about $540 million across roughly 30 institutions, even as SOL trade...
As the partial government shutdown stretches into weeks, houston airport, with nearly 40% TSA absences, becomes a foc...